Published in Medical Letter on the CDC and FDA, October 9th, 2005
"Effector mechanisms responsible for providing protective immunity against Plasmodium vivax (Pv) infection were examined in Aotus monkeys vaccinated with two Pv merozoite surface protein-1 (PvMSP-1) recombinant polypeptides that had previously been shown to protect vaccines against parasite challenge," scientists in Colombia report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA